Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 clinical study from Zhejiang University is evaluating the safety and efficacy of CD7 CAR-T cell sequential allogeneic hematopoietic stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schimke-immuno-osseous Dysplasia

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: Zhejiang University | Conditions: Schimke Immuno-osseous Dysplasia | EARLY_Phase 1 | Status: RECRUITING